Carmignac Gestion Merck & Co., Inc. Transaction History

Carmignac Gestion

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $46.1 Million - $54.3 Million	-669,015 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $108 Million - $120 Million	-1,507,430 Reduced 69.26%	669,015 $54.7 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $256,130 - $290,325	-3,500 Reduced 0.16%	2,176,445 $181 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $35.1 Million - $40 Million	498,936 Added 29.68%	2,179,945 $169 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $26.2 Million - $36.3 Million	413,334 Added 32.61%	1,681,009 $129 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $98.3 Million - $111 Million	1,267,675 New	1,267,675 $115 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $102 Million - $111 Million	-1,334,894 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $41.1 Million - $48 Million	-587,944 Reduced 30.58%	1,334,894 $112 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $134 Million - $153 Million	1,922,838 New	1,922,838 $160 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.